Table 3 Comparison of patient characteristics at first CAVI test in patients with and without impaired CAVI

From: Serial assessment of arterial stiffness by cardio-ankle vascular index for prediction of future cardiovascular events in patients with coronary artery disease

 

Patients with persistently impaired CAVI (n=105)

Patients with improved CAVI (n=106)

P-value

Age, years

64±11

66±8

0.2

Male, n (%)

63 (60)

55 (52)

0.2

Hypertension, n (%)

74 (71)

79 (75)

0.6

Hyperlipidemia, n (%)

68 (65)

73 (69)

0.5

Diabetes, n (%)

61 (59)

53 (50)

0.2

Multi-vessel CAD, n (%)

35 (33)

43 (41)

0.3

Systolic BP, mm Hg

148±26

142±21

0.1

Diastolic BP, mm Hg

85±10

83±10

0.1

Heart rate, b.p.m.

69±12

70±13

0.3

Body mass index, kg m–2

24.4±3.2

24.3±2.4

0.8

Current smoker, n (%)

25 (30)

31 (35)

0.5

LDL cholesterol, mg dl–1

119±30

114±35

0.5

HDL cholesterol, mg dl–1

51±12

49±13

0.5

Fasting glucose, mg dl–1

129±38

130±39

0.9

HbA1c, %

6.4±0.8

6.3±1.1

0.4

CRP, mg l–1

1.5±1.5

1.7±1.9

0.6

Mean IMT, mm

0.86±0.18

0.86±0.19

0.9

First ba-PWV, m s–1

17.1±2.4

17.3±3.0

0.5

First CAVI

9.87±0.65

10.05±0.78

0.07

  1. Abbreviations: ba-PWV, brachial-ankle pulse wave velocity; BP, blood pressure; CAD, coronary artery disease; CAVI, cardio-ankle vascular index; CRP, C-reactive protein; Hb, hemoglobin; HDL, high-density lipoprotein; IMT, intima-media thickness; LDL, low-density lipoprotein.
  2. Values are mean±s.d. or n (percentage). The column showed P-values for the comparison between patients with persistently impaired CAVI and those with improved CAVI.
Back to article page